Proteomics

Dataset Information

0

Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaks


ABSTRACT: The project is about studying the dynamics of PARP1 when bound to DNA and veliparib derivatives.

INSTRUMENT(S): Exactive Plus

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Ramya Billur  

LAB HEAD: Dr. Ben E. Black

PROVIDER: PXD047072 | Pride | 2024-03-19

REPOSITORIES: Pride

altmetric image

Publications

Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaks.

Velagapudi Uday Kiran UK   Rouleau-Turcotte Élise É   Billur Ramya R   Shao Xuwei X   Patil Manisha M   Black Ben E BE   Pascal John M JM   Talele Tanaji T TT  

The Biochemical journal 20240301 6


Catalytic poly(ADP-ribose) production by PARP1 is allosterically activated through interaction with DNA breaks, and PARP inhibitor compounds have the potential to influence PARP1 allostery in addition to preventing catalytic activity. Using the benzimidazole-4-carboxamide pharmacophore present in the first generation PARP1 inhibitor veliparib, a series of 11 derivatives was designed, synthesized, and evaluated as allosteric PARP1 inhibitors, with the premise that bulky substituents would engage  ...[more]

Similar Datasets

2021-01-20 | PXD017931 | Pride
2020-12-11 | PXD018007 | Pride
2021-02-22 | PXD022831 | Pride
2024-02-01 | PXD049090 | Pride
2022-02-17 | PXD026580 | Pride
2021-10-12 | PXD022861 | Pride
2013-05-26 | E-GEOD-37635 | biostudies-arrayexpress
2021-04-08 | PXD019884 | Pride
2023-09-08 | PXD045012 | Pride
2021-06-14 | PXD024604 | Pride